Madeleine Farman
Madeleine Farman is a senior reporter for PEI Group’s Private Equity International and Secondaries Investor titles, based in London. Prior to joining PEI, she had covered private equity, private capital and advisers associated with the industry for other newsrooms and publications since 2016. Originally from New Zealand, Madeleine began her career in radio in Auckland.
EQT Healthcare Growth will back businesses that have de-risked from a scientific point of view and are at a pivotal stage of development, EQT's healthcare co-head tells PEI.
Market participants give their predictions for the secondaries market, noting that the amount of dry powder available will limit activity and leave buyers able to cherry-pick transactions.
PEI caught up with fundraising experts to discuss Asia-Pacific reallocations, tricky re-ups and incentives managers will use to lure investors this year.
For many fund managers, 2023 has been a year for creativity when trying to entice LP capital.
Covalent, and which aims to pool LP resources, will focus on mid-market buyouts and growth equity financings in North America and Europe, according to Wafra's Steve Moseley and AP3's Henrik Nordlander.
Not only are LPs looking to commit capital to the strategy, there is also increasing demand for GP-led exposure.
The region’s mid-market private equity firms are being even more selective at a time when sector specialisation is key.
A recent continuation fund exit by TPG is further evidence that such vehicles can reward investors with the capacity and desire to roll over, or those who opt to back funds investing in these deals.
The investment arm of Peruvian conglomerate Grupo Romero will look to back Hispanic businesses across the Americas.
A portion of the NAV facility will be used to issue distributions back to LPs and is recallable if needed in the future, Private Equity International understands.